Leaflet VITREOLENT 3mg / 3mg / ml ophthalmic solution
Indicated for: mineral deficiency; mineral supplementation
Route of administration: ophthalmic
Substance: potassium iodide + sodium iodide (minerals)
ATC: S01XA20 (Sensory organs | Other ophthalmologicals)
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
The combination of potassium iodide and sodium iodide is used for the prevention and treatment of iodine deficiency, particularly in situations of radiation exposure. It helps protect the thyroid gland by blocking the uptake of radioactive iodine.
The medication is taken orally, usually in the form of a solution or tablets, as directed by a doctor. It is important to follow the recommended dose to avoid side effects.
Side effects may include nausea, gastric irritation, skin rashes, or a metallic taste. In rare cases, severe allergic reactions or iodine-induced hyperthyroidism may occur.
This combination is not recommended for patients with hypersensitivity to iodine, active hyperthyroidism, or dermatitis herpetiformis.
General data about VITREOLENT 3mg / 3mg / ml
- Substance: potassium iodide + sodium iodide
- Date of latest medicines list: 01-07-2013
- Product code: W13216001
- Concentration: 3mg / 3mg / ml
- Pharmaceutical form: ophthalmic solution
- Quantity: 1
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.